4337 related articles for article (PubMed ID: 6287961)
1. Immunohistochemical acid phosphatase level and tumor grade in prostatic carcinoma.
Bentz MS; Cohen C; Demers LM; Budgeon LR
Arch Pathol Lab Med; 1982 Sep; 106(9):476-80. PubMed ID: 6287961
[TBL] [Abstract][Full Text] [Related]
2. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
3. Carcinoembryonic antigen and human chorionic gonadotrophin in breast carcinoma and prostatic specific acid phosphatase in prostate carcinoma.
Arora B; Chhabra A; Yadav MS; Arora DR
Indian J Pathol Microbiol; 1990 Jul; 33(3):235-8. PubMed ID: 1965432
[TBL] [Abstract][Full Text] [Related]
4. Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia.
Jack GS; Brash AR; Olson SJ; Manning S; Coffey CS; Smith JA; Shappell SB
Hum Pathol; 2000 Sep; 31(9):1146-54. PubMed ID: 11014584
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma.
Genega EM; Hutchinson B; Reuter VE; Gaudin PB
Mod Pathol; 2000 Nov; 13(11):1186-91. PubMed ID: 11106075
[TBL] [Abstract][Full Text] [Related]
6. Prostatic acid phosphatase immunoperoxidase staining of cytologically positive effusions associated with adenocarcinomas of the prostate and neoplasms of undetermined origin.
Broghamer WL; Richardson ME; Faurest S; Parker JE
Acta Cytol; 1985; 29(3):274-8. PubMed ID: 3890441
[TBL] [Abstract][Full Text] [Related]
7. Telomerase reverse transcriptase subunit immunoreactivity: a marker for high-grade prostate carcinoma.
Iczkowski KA; Pantazis CG; McGregor DH; Wu Y; Tawfik OW
Cancer; 2002 Dec; 95(12):2487-93. PubMed ID: 12467061
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI
Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder.
Lane Z; Hansel DE; Epstein JI
Am J Surg Pathol; 2008 Sep; 32(9):1322-6. PubMed ID: 18670358
[TBL] [Abstract][Full Text] [Related]
10. Fine needle aspiration cytology of prostatic adenocarcinoma metastatic to the lung confirmed by the immunoperoxidase technique.
Bartziota EV
Acta Cytol; 1986; 30(5):497-500. PubMed ID: 2430390
[TBL] [Abstract][Full Text] [Related]
11. Correlation between immunohistochemical patterns and serum levels of PSA and PSAP in prostatic pathology: evaluation of 198 prostatic fine needle biopsies.
Vitali A; Ardoino S; Durante P; Ferro MA; Li Causi F; Parodi C; Sanguineti G; Gaffuri M; Paerachino M; Salvadori RP
Anticancer Res; 1994; 14(4A):1503-7. PubMed ID: 7526771
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of prostate-specific acid phosphatase in prostate cancer: reproducibility and correlation with subjective grade.
Zhou R; Hammond EH; Sause WT; Rubin P; Emami B; Pilepich MV; Asbell SD; Parker DL
Mod Pathol; 1994 May; 7(4):440-8. PubMed ID: 7520585
[TBL] [Abstract][Full Text] [Related]
13. A simple immunohistochemical method for the detection of prostatic acid phosphatase.
Lee P; Lam KW; Li CY; Yam LT
Arch Pathol Lab Med; 1981 Apr; 105(4):205-6. PubMed ID: 7011253
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical identification of prostatic acid phosphatase: correlation of tumor grade with acid phosphatase distribution.
Bates RJ; Chapman CM; Prout GR; Lin CW
J Urol; 1982 Mar; 127(3):574-80. PubMed ID: 6174741
[TBL] [Abstract][Full Text] [Related]
15. Human telomerase and alpha-methylacyl-coenzyme A racemase in prostatic carcinoma. A comparative immunohistochemical study.
Puebla-Mora AG; Heras A; Cano-Valdez AM; Domínguez-Malagón H
Ann Diagn Pathol; 2006 Aug; 10(4):205-8. PubMed ID: 16844561
[TBL] [Abstract][Full Text] [Related]
16. Correlation of survival with quantitative tissue staining of prostate specific acid phosphatase in patients with prostate carcinoma by using microscopic image analysis: a preliminary report of correlative studies on RTOG protocols 75-06, 77-06, and 83-07.
Zhou R; Sause WT; Hammond EH; Rubin P; Perez C; Pilepich MV; Asbell SD; Parker DL
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):823-9. PubMed ID: 7591889
[TBL] [Abstract][Full Text] [Related]
17. Prostatic adenocarcinoma metastases mimicking small cell carcinoma on fine-needle aspiration.
Parwani AV; Ali SZ
Diagn Cytopathol; 2002 Aug; 27(2):75-9. PubMed ID: 12203872
[TBL] [Abstract][Full Text] [Related]
18. Lewis Y antigen as detected by the monoclonal antibody BR96 is expressed strongly in prostatic adenocarcinoma.
Myers RB; Srivastava S; Grizzle WE
J Urol; 1995 May; 153(5):1572-4. PubMed ID: 7714977
[TBL] [Abstract][Full Text] [Related]
19. The role of the radioimmunoassay for prostatic acid phosphatase in prostatic carcinoma.
Bruce AW; Mahan DE; Belville WD
Urol Clin North Am; 1980 Oct; 7(3):645-52. PubMed ID: 7456177
[TBL] [Abstract][Full Text] [Related]
20. Expression of tumor-associated glycoprotein 72 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
Myers RB; Schlom J; Srivastava S; Grizzle WE
Mod Pathol; 1995 Apr; 8(3):260-5. PubMed ID: 7617651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
